Accessibility Information

Users of assistive technologies such as screen readers should use the following link to activate Accessibility Mode before continuing: Learn more and Activate accessibility mode.

Internet Monitoring

Solicitation Number: FDA-RFI-1113738
Agency: Department of Health and Human Services
Office: Food and Drug Administration
Location: Office of Acquisitions and Grants Services
  • Print

Note:

There have been modifications to this notice. To view the most recent modification/amendment, click here
:
FDA-RFI-1113738
:
Sources Sought
:
Added: Mar 21, 2013 9:23 am
Food and Drug Administration
FDA-RFI-1113738
Internet Monitoring


Notice to All Businesses
The purpose of this Sources Sought Notice is to seek declarations of technical capabilities and various information, data, and materials from all qualified business concerns [including Small Businesses, SBA Certified 8(a) Small Businesses, Woman-owned Small Businesses (WOSB), Historically Underutilized Business Zone (HUBZone), and Service-Disabled Veteran-owned Small Businesses (SDVOSB)]. Food and Drug Administration intends to provide maximum practicable opportunities in its acquisitions to small business, service-disabled veteran-owned small business, HUBZone small business, SBA certified 8(a) small business.


Background
This Sources Sought Request for Information (RFI) is for information, planning and market research purposes only and shall not be construed as either a solicitation or obligation on the part of the Food and Drug Administration or its Centers. The purpose of this RFI is to help the FDA understand the industry best practices and technical solutions capable of providing the full range of services described in this RFI and the draft SOW. FDA will use this market research information to assess the market's capability to successfully meet FDA's Internet Monitoring requirements.


FDA welcomes responses from all interested businesses. FDA does not intend to make a selection decision or award a contract on the basis of responses nor otherwise pay for the preparation of any information submitted or FDA's use of such information. Acknowledgment of receipt of responses will not be made, no questions will be answered, nor will respondents be notified of the outcome of the FDA's review of the information received. Additionally, the FDA does not intend to hold discussions concerning this RFI with any interested parties. However, FDA reserves the right to contact vendors if additional information is required.


General Instructions


Responses to the RFI should not exceed 10 pages in length, excluding the Key Capabilities Matrix. They should be submitted via email to Sherry Rowlett at sherry.rowlett@fda.hhs.gov by 12:00 noon on April 1, 2013. E-Mail is the only acceptable method of delivery for this sources sought notice.


A complete response to the RFI should include answers to all of the questions below, plus completion of the Key Capabilities Matrix. Please note that a respondent's failure to provide a complete response to a question will be interpreted to mean that it does not understand the question and does not demonstrate the capability to provide services required. Responses should demonstrate capability, not merely affirm the respondent's capability (e.g.: The response must go beyond the statement that, "XYZ company can provide training support.").



Questions:


1. On the FACE PAGE of your response, please provide the following:
a. Organization name
b. DUNS number
c. Organization's website
d. Contact Name
e. Contact Telephone
f. Contact E-mail address
g. Size designation
h. Number of employees in your organization
i. Your organization's current and gross revenue


2. Please provide documentation of the size of your business. If you are classified as a small business, Historically Underutilized Business Zone small business, Service Disabled Veteran Owned Small Business, Woman-Owned Small Business and/or SBA 8(a) certified small business, please provide a capability statement in addition to the other information for acquisition strategy determination. Additionally, please demonstrate your firm's capability to meet the requirements of FAR 52.219-14, Limitations on Subcontracting.


3. Describe your company's experience with identifying and mapping illegal online pharmacy networks.


4. Identify your company's existing technical capabilities in identifying and mapping illegal online pharmacy networks. For example, describe current software programs you utilize to obtain open-source information. Do you currently have networked infrastructure in place to support an effort such as this?


5. List the experience your existing personnel have with open source-information collection and identifying and mapping illegal online pharmacy networks.


6. Does your company currently have existing contracts or business relations with any other company that produces or distributes any FDA-regulated products? (pharmaceuticals, medical devices, foods, tobacco, biologics, dietary supplements)


7. Detail your current information security standards and protocol.


8. Do your personnel have current security clearances? If so, what classification(s)?


9. Are your personnel available to testify in court or other proceedings?


10. Are your personnel available to travel?


11. Describe your company's current ability to de-conflict information with other law enforcement agencies.


12. Describe your company's current capabilities to de-conflict information internally.


13. Describe your company's current relationship with other businesses that support the architecture of the internet.


14. Has your company ever performed straw purchases? Briefly describe what was bought and the process.


15. Detail the knowledge and experience your existing personnel have with the Food, Drug and Cosmetic Act (Title 21, U.S.C. § 301 et. seq)


16. Do any gaps exist in the Draft Statement of Work? If so, what are they? What changes, additions, updates, and clarifications would you suggest?


17. Please provide a list of suggested Labor Categories to support the work described in the draft SOW. Include a brief narrative description of each Labor Category that identifies education, certification, and experience you deem critical or necessary to successfully execute this work. Please describe the difference between senior and junior level categories. Discuss methods of attracting and retaining expertise, whether within your firm or by using partners/subcontractors, and describe any certifications that demonstrate proven management and quality outcomes.


18. Please provide a rough order of magnitude (ROM) for the work currently contained in the Draft Statement of Work.


19. Please provide suggested appropriate North American Industry Classification System (NAICS) code and rationale.


20. Provide information concerning contract vehicles available to be used by the FDA in acquiring the services outlined in the draft SOW (GSA Federal Schedules, Government wide Acquisition Contract, etc.).


21. Please complete the Key Capabilities Matrix.


Attachments:
1. Draft Statement Of Work
2. Key Capabilities Matrix

Please consult the list of document viewers if you cannot open a file.

RFI Instructions

Type:
Other (Draft RFPs/RFIs, Responses to Questions, etc..)
Label:
RFI Instructions
Posted Date:
March 21, 2013
Description: RFI Instructions
Description: Draft SOW

Key Capabilities Matrix

Type:
Other (Draft RFPs/RFIs, Responses to Questions, etc..)
Label:
Key Capabilities Matrix
Posted Date:
March 21, 2013
Description: Key Capabilities Matrix

Amendment 1

Type:
Mod/Amendment
Posted Date:
March 29, 2013
Description: Amendment - Extension of Deadline

Amendment 2

Type:
Mod/Amendment
Posted Date:
April 2, 2013
Description: Amendment 2
:
5630 Fishers Lane, Room 2129
Rockville, Maryland 20857-0001
:
5630 Fishers Lane
Rockville, Maryland 20857
United States
:
Sherry Rowlett,
Contracting Officer
:
Jennifer Fagan,
Contracting Officer